港版氢化可的松片功效与作用

On September 29, 2020, Eton Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved oral granules as an alternative therapy for the treatment of adrenocortical insufficiency (AI) in children under 17 years of age. Today let’s learn about the efficacy and functions of the Hong Kong version of hydrocortisone tablets.

Hydrocortisone tablets are an alternative treatment for adrenal insufficiency and congenital adrenal hyperplasia. It has shown remarkable clinical efficacy and has become an important treatment option for patients with indications.

A domestic study divided 50 patients with moderate and severe craniocerebral injuries into an observation group and a control group, with 25 cases each. The control group received conventional treatment; the observation group, on the basis of the control group, was given hydrocortisone in the early stage of illness (within 3 hours) at a dose of 2 mg/(kg·d), divided into 3 times, and added with normal saline to 0.2 mg/ml for 3 days. Changes in plasma cortisol, blood sugar, C-reactive protein levels and the number of white blood cells were detected at different time points after medication; 7 days later, the patients were subjected to an adrenocorticotropic hormone (ATCH) stimulation test to detect plasma cortisol content and judge the recovery of the patient's adrenal cortisol function.

The results of the study showed that the plasma cortisol, blood glucose C-reactive protein levels and white blood cell count of the two groups of patients were higher at the beginning of admission. After treatment, these four indicators in the observation group were significantly lower than before treatment. The comparison between the groups was statistically significant (P<0.05). Compared with the control group at the same time point, they were also significantly lower. The comparison between the groups was statistically significant (P<0.05). After ATCH stimulation, the increase in cortisol level in the observation group was higher than that in the control group, and the comparison between the groups was statistically significant (P<0.05).

The final study concluded that hydrocortisone can significantly reduce plasma cortisol, blood sugar, C-reactive protein levels and white blood cell counts in patients with early acute moderate and severe craniocerebral injury, contribute to the recovery of patients' adrenal cortex function, and has a good therapeutic effect.

Hydrocortisone tablets are produced and sold by Bristol-Myers Squibb Company. For domestic patients, they can choose to buy hydrocortisone tablets sold in China. Currently, hydrocortisone tablets are not marketed in mainland China, so they are not a medically insured drug. Hydrocortisone tablets have been launched in Hong Kong, China, and a box is priced at about RMB 1,000. If domestic patients need it, they can contact domestic professional and formal overseas medical service organizations (such as Medical Companion Travel) to obtain the medicine, or they can purchase it in person in Hong Kong.

The above is the content of the functions, I hope it can help you!